as 11-13-2024 4:00pm EST
Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
Founded: | 2016 | Country: | United States |
Employees: | N/A | City: | CAMBRIDGE |
Market Cap: | 165.5M | IPO Year: | 2020 |
Target Price: | $7.50 | AVG Volume (30 days): | 137.7K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -2.19 | EPS Growth: | N/A |
52 Week Low/High: | $1.06 - $4.65 | Next Earning Date: | 11-06-2024 |
Revenue: | $18,582,000 | Revenue Growth: | 514.08% |
Revenue Growth (this year): | 99.36% | Revenue Growth (next year): | -43.78% |
GBIO Breaking Stock News: Dive into GBIO Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Simply Wall St.
6 days ago
Zacks
7 days ago
GlobeNewswire
7 days ago
Simply Wall St.
13 days ago
Simply Wall St.
14 days ago
GlobeNewswire
23 days ago
GlobeNewswire
2 months ago
The information presented on this page, "GBIO Generation Bio Co. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.